[Treatment of urogenital tuberculosis with ofloxacin. Preliminary study]. / Tratamiento de la tuberculosis génito-urinaria con ofloxacina. Estudio preliminar.
Actas Urol Esp
; 16(1): 64-8, 1992 Jan.
Article
en Es
| MEDLINE
| ID: mdl-1590076
ABSTRACT
Ofloxacin is a new fluoride quinolone which has been shown to be active both in vitro and in vivo against Mycobacterium tuberculosis. This prospective study presents the results obtained with a new protocol for the treatment of genito-urinary tuberculosis. The comparison drugs were Ofloxacin 200 mg every 12 hours for 6 months, Rifampicin 600 mg every 24 for 3 months and Isoniazid 300 mg every 24 hours for 3 months. The results, were clinically and microbiologically good. It is concluded that this new drug should be a valid alternative to the traditional therapy.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Tuberculosis Urogenital
/
Ofloxacino
Tipo de estudio:
Guideline
/
Observational_studies
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Es
Revista:
Actas Urol Esp
Año:
1992
Tipo del documento:
Article